GERN
Geron Corporation
๐บ๐ธ NYSE/NASDAQ
๐ HIGH PRICE GROWTH
๐ Overview
๐ Performance
๐ต Cost
๐ Esg
๐ค Advanced
๐จโ๐ฉโ๐งโ๐ฆ Community
๐
+ 36.05%
Annual Growth
5 years average annual growth
๐
1
Pearlers Invested
Since January 2020
๐ Overview
Key information
๐ Fund Overview
Geron Corporation is a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies. The Company is engaged in the development of therapeutic products for oncology. Its lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes. It is developing imetelstat for the treatment of several myeloid hematologic malignancies, including a Phase 3 clinical trial, named IMpactMF, in relapsed/refractory myelofibrosis (MF) with overall survival as the primary endpoint, that is enrolling patients. It is also conducting a Phase 1 combination therapy clinical trial, named IMproveMF, in first-line Intermediate-1, Intermediate-2 or High-Risk myelofibrosis, or frontline MF, that is enrolling patients and imetelstat is being studied in an investigator-led Phase 2 clinical trial, named IMpress, in Intermediate-2 or High-Risk myelodysplastic syndromes and acute myeloid leukemia.
๐ Performance
Price History*
+54.31%
1M
1Y
10Y
Graph
Table
* US price history does not take into account stock splits
Unsure how much or often to invest?
๐๏ธ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out โ๐ต Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out โโฑ๏ธ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out โ๐ต Costs
๐ผ
N/A
Management Fee
Included in unit price, not charged by Pearler
๐ธ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐ธ Net fee calculator๐ค Advanced information
Technical Info
๐ฐ Price*
$4.12
*Price may be up to 24 hours old
๐ฉโ๐ฉโ๐ฆ Community Insights
How our community is investing
๐ Pearlers invested in GERN
1
๐ Total Capital Earnings
N/A
๐ Average investment frequency
28 weeks
๐ต Average investment amount
$208
โฐ Last time a customer invested in GERN
23 days
GERN investor breakdown
๐ต Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
100%
Less than 50k
๐ถ Age of investors
18 - 25
26 - 34
35 - 90
100%
๐ Legal gender of investors
Female
100%
Male
Pearlers who invest in GERN also invest in...
๐ Performance (5Yr p.a)
494.41%
๐ Share price
$135.40 USD
๐ HIGH PRICE GROWTH
๐ Performance (5Yr p.a)
53.98%
๐ Share price
$57.15 USD
Want more shares? Try these...
๐ Performance (5Yr p.a)
-4.97%
๐ Share price